Yes. The Intrinsic LifeSciences laboratory developed Hepcidin test and tracer are patented
(Patent # 7,723,063 and 7,745,162).
Currently the hepcidin assay is not FDA approved. However, it has been validated in several peer-reviewed studies and is marketed as a Research Use Only assay. It is offered for academic, clinical, government and pharmaceutical customers, worldwide.

No, this is an RUO test. To order our diagnostic test, the Intrinsic Hepcidin IDx^TM Test, please go to IntrinsicDx - Order Tests / Specimen Collection & Shipping Instructions.

Hepcidin is measured in plasma, serum, urine and other body fluids using a patented tracer and a competitive enzyme-linked immunosorbent assay (ELISA).

src="http://ilswp88.staging.wpengine.com/wp-content/uploads/2020/11/Picture1-300x218.png" alt="" width="250" />The yellow Y-shaped figures represent the hepcidin antibodies, the blue balls represent serum hepcidin, the blue and red balls represent the ILS patented biotinylated hepcidin tracer molecule, and the green figures represent the detection reagent which emits a signal that is detected and quantified.

In serum and plasma, hepcidin is stable for at least 6 years when samples are stored either at -80°C or -20°C. In urine, hepcidin is stable for 6 months at -80°C.

Hepcidin concentrations can be reported as either nM or ng/ml. To convert between the two units use the following calculations:  1 nM = 2.789 ng/ml or 1 ng/ml = 0.358 nM.

Hepcidin could be present in virtually any body fluid. To date we have measured hepcidin in plasma, serum, urine, saliva, cerebral spinal fluid, cord blood, amniotic fluid and peritoneal dialysis fluid.